[
  {
    "title": "何氏眼科(301103.SZ)：拟使用超募资金2600万元向博鳌何氏眼科增资、用于筹建海南何氏睛彩商贸",
    "href": "http://stock.jrj.com.cn/2022/09/15182236997924.shtml",
    "datetime": "2022-09-15 18:22:27",
    "code": "301103"
  },
  {
    "title": "何氏眼科(301103.SZ)2021年度权益分派10转3派6元 股权登记日为5月31日",
    "href": "http://stock.jrj.com.cn/2022/05/25213036679037.shtml",
    "datetime": "2022-05-25 21:30:50",
    "code": "301103"
  },
  {
    "title": "何氏眼科（301103.SZ）：高景气黄金赛道下，创新商业模式价值凸显",
    "href": "http://stock.jrj.com.cn/2022/05/09111336603957.shtml",
    "datetime": "2022-05-09 11:13:43",
    "code": "301103"
  },
  {
    "title": "【龙虎榜】何氏眼科3月22日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/22180034861387.shtml",
    "datetime": "2022-03-22 18:00:06",
    "code": "301103"
  },
  {
    "title": "何氏眼科(301103.SZ)上市首日一度大涨近40%",
    "href": "http://stock.jrj.com.cn/2022/03/22105734859769.shtml",
    "datetime": "2022-03-22 10:57:45",
    "code": "301103"
  },
  {
    "title": "何氏眼科（301103.SZ）：业绩稳健增长，布局消费医疗蓝海未来可期",
    "href": "http://stock.jrj.com.cn/2022/03/21084934854014.shtml",
    "datetime": "2022-03-21 08:49:10",
    "code": "301103"
  },
  {
    "title": "何氏眼科(301103.SZ)将于3月22日在深交所上市",
    "href": "http://stock.jrj.com.cn/2022/03/20172634852208.shtml",
    "datetime": "2022-03-20 17:26:20",
    "code": "301103"
  },
  {
    "title": "何氏眼科(301103.SZ)：回拨后网上发行的中签率为0.0175675132%",
    "href": "http://stock.jrj.com.cn/2022/03/10193534810563.shtml",
    "datetime": "2022-03-10 19:35:53",
    "code": "301103"
  },
  {
    "title": "何氏眼科(301103.SZ)IPO定价为42.50元/股 3月10日申购",
    "href": "http://stock.jrj.com.cn/2022/03/08203734542430.shtml",
    "datetime": "2022-03-08 20:37:52",
    "code": "301103"
  },
  {
    "title": "何氏眼科(301103.SZ)：网上路演时间为3月9日14:00-17:00",
    "href": "http://stock.jrj.com.cn/2022/03/07210734538889.shtml",
    "datetime": "2022-03-07 21:07:13",
    "code": "301103"
  },
  {
    "title": "何氏眼科IPO三虑：“民非”重组 医疗纠纷 家族控股",
    "href": "http://stock.jrj.com.cn/2021/09/15082833437942.shtml",
    "datetime": "2021-09-15 08:28:00",
    "code": "301103"
  },
  {
    "title": "说明实控人垫付费用对应的支付对象等，何氏眼科回复IPO第二轮问询",
    "href": "http://stock.jrj.com.cn/2021/02/24085332016622.shtml",
    "datetime": "2021-02-24 08:53:42",
    "code": "301103"
  },
  {
    "title": "34家控股子公司23家亏损 何氏眼科称不会影响公司持续经营能力",
    "href": "http://stock.jrj.com.cn/2020/12/07141231429772.shtml",
    "datetime": "2020-12-07 14:12:30",
    "code": "301103"
  },
  {
    "title": "何氏眼科创业板获受理：去年研发费用率为0.77%",
    "href": "http://stock.jrj.com.cn/2020/08/19161130539069.shtml",
    "datetime": "2020-08-19 16:11:47",
    "code": "301103"
  },
  {
    "title": "新冠肺炎治疗用药拟纳入医保 何氏眼科等3家眼科企业集中冲刺创业板 | 医资日报",
    "href": "http://stock.jrj.com.cn/2020/08/05185830434642.shtml",
    "datetime": "2020-08-05 18:58:16",
    "code": "301103"
  },
  {
    "title": "7家企业“赶考”创业板 何氏眼科股东阵营豪华",
    "href": "http://stock.jrj.com.cn/ipo/2020/07/30065730378637.shtml",
    "datetime": "2020-07-30 06:57:12",
    "code": "301103"
  },
  {
    "title": "[新集能源]国投与何氏眼科集团签署战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2018/04/23000024432588.shtml",
    "datetime": "2018-04-23 00:00:00",
    "code": "301103"
  }
]